Recovery Month: Pathways to Recovery

Mark Twain had a funny retort about quitting smoking: “Giving up smoking is easy. I’ve done it hundreds of times.”

In other words, change is hard.

As we observe Recovery Month throughout September, it’s important to acknowledge how common substance use disorders have become. The release on July 30 of the 2023 National Survey on Drug Use and Health (NSDUH) provided a glimpse. According to the report:

Among this group, 28.9 million people (10.2%) had an alcohol use disorder in 2023, compared to 29.5 million in 2022.

And while substance use disorders are common, treatment is not: Among the 48.5 million people who had a substance use disorder in the past year, 41.4 million people (85.4%) did not receive treatment.

One challenge is helping people get the treatment they want and need, and it’s important to recognize that treatment will look different for everyone.

We also know, thanks to the Recovery Research Institute, that many people don’t seek a formal treatment program, and the lines between clinical and nonclinical approaches are blurring with the advent of telehealth, health apps and AI-assisted technologies.

We must be prepared to support people in all aspects of their recovery and be equipped to offer them a range of services and supports when and where they need them. That requires new thinking and new approaches.

Here’s one: Integrating treatment for substance use with primary care is gaining momentum. An increasing number of primary care doctors are prescribing medications for alcohol and other substance use disorders, although the need still vastly outweighs the availability of such treatments. Better integration and care coordination are tied to better outcomes and can reduce relapse or recurrence.

If we move away from an exclusive focus on abstinence, we can expand prevention, treatment and recovery supports in nontraditional ways. That could significantly reduce the rising number of overdose deaths.

By embracing and integrating a broader range of approaches, including harm reduction strategies, we can provide lifesaving services and early intervention supports. Fentanyl test strips successfully detect the presence of illicit fentanyl, which has become increasingly prominent. Synthetic opioids, primarily fentanyl, remain the most lethal problem we face in the overdose crisis; fentanyl can be 50 to 100 times more powerful than morphine, according to the National Institute on Drug Abuse.

Making the overdose-reversal drug naloxone more widely available already has helped reduce overdose deaths, and we should continue efforts to make it easy for everyone to obtain that lifesaving drug.

We can make significant progress in helping people with substance use disorders by building compassionate, integrated systems of whole-person care that meet people where they are. These culturally responsive systems should offer a range of treatment and harm reduction options, creating multiple pathways toward a more broadly defined sense of recovery.

Recovery takes many forms, so we must empower people to find their own way. Let’s do all we can to help them. Please share your reflections on this important topic, and check out our National Recovery Month resources.

And don’t forget about our upcoming webinar, Mental Health Barriers in the Workplace – Navigating and Supporting Employee Wellbeing, on Tuesday, Oct. 1. Panelists from Kate Spade New York, Kaiser Permanente and Lendlease Foundation will discuss strategies to identify mental health barriers in the workplace, how to create a supportive culture that reduces stigma and share insights into essential mental health training programs ahead of World Mental Health Day on Oct. 10.